ASCRS 2026: New Data Highlight Performance of TECNIS PureSee EDOF IOL - Takeaway - MDSpire
Clinical Guidelines
Feature

ASCRS 2026: New Data Highlight Performance of TECNIS PureSee EDOF IOL

New data highlight visual outcomes and patient experience

  • April 10, 2026

  • 3 min

Share

  • 1

    TECNIS PureSee IOL enhances vision beyond standard lenses.

  • 2

    Data presented at 2026 ASCRS in Washington, DC.

  • 3

    Randomized trial showed improved distance vision.

  • 4

    94% of patients maintained 20/25 visual acuity.

  • 5

    High patient satisfaction with low visual disturbance.

  • 6

    Post-market data confirmed strong real-world performance.

  • 7

    Innovation within the TECNIS platform continues.

Original Source(s)

ASCRS 2026: New Data Highlight Performance of TECNIS PureSee EDOF IOL

  • April 10, 2026

Related Content

ASCRS 2026: Sightview to Showcase Updated EHR Platform

Updated user experience and workflows aim to support ophthalmology practices

  • April 10, 2026

  • 1 min
The Optimism of Optogenetics for Vision Restoration

Bridging light to sight – optogenetic gene therapies show vision gains but need refinement for clinical maturity

Built for Physicians, Designed for Precision

The Elara 900 expands on the existing gold-standard optics of Haag-Streit’s BQ 900, redefining the slit lamp experience for both physicians and patients

  • April 9, 2026

  • 7 min